Carlstar Group Sued for Disability Discrimination Over Prescription Medication Policy

Background

Workplace disability discrimination continues to be a major concern for employees who rely on prescription medications to manage chronic conditions. Federal law prohibits employers from penalizing qualified workers based on their legal use of such medications. A recent lawsuit filed by the U.S. Equal Employment Opportunity Commission (EEOC) targets a tire manufacturing company for allegedly terminating or limiting employment opportunities for individuals who were medically cleared but used prescribed medications for disabilities.

Incident Details

The Carlstar Group LLC, a Tennessee-based manufacturer of specialty tires and wheels, is accused of violating federal disability law by taking adverse employment actions against workers who were lawfully using prescription medications, including opioids and other narcotics. These actions allegedly took place at its facilities in Clinton and Jackson, Tennessee, and Aiken, South Carolina.

According to the EEOC's complaint, since at least January 2020, Carlstar either terminated or denied work opportunities to employees after discovering their prescribed medication use—even when those employees had been medically cleared to perform their job functions safely. The company is also accused of failing to explore or offer reasonable accommodations to its substance abuse and drug testing policies that would allow these individuals to work while using their prescribed treatments.

Legal Background

The Americans with Disabilities Act (ADA) prohibits employers from discriminating against qualified individuals with disabilities. This includes individuals who are lawfully using prescription medications under the supervision of a medical professional. Employers are required to evaluate employees on an individual basis and must consider reasonable accommodations unless doing so would impose an undue hardship.

Blanket employment policies that exclude workers based solely on their use of certain medications—without considering their ability to safely and effectively perform job duties—can constitute unlawful discrimination under the ADA.

Settlement and Relief

As of the filing, the case remains pending in the U.S. District Court for the Middle District of Tennessee (Case No. 3:25-cv-00575). The EEOC is seeking:

• Monetary relief for affected employees, including back pay, compensatory damages, and punitive damages.
• A court order mandating policy changes to prevent future discrimination.
• Training requirements for management and HR personnel to ensure compliance with ADA regulations.

If granted, these measures aim to rectify alleged past harms and prevent ongoing or future discriminatory practices.

Key Takeaways

1. Prescription Use Alone Is Not Grounds for Termination: Employees lawfully taking medications under medical supervision are protected under the ADA.
2. One-Size-Fits-All Policies Can Violate the ADA: Employers must assess each case individually and offer accommodations where feasible.
3. Medical Clearance Matters: When a doctor confirms an employee can safely perform their job, employers must consider that determination seriously before taking adverse action.

Conclusion

The Carlstar case underscores the legal obligations employers have under the ADA to treat employees who use prescription medications fairly and on an individualized basis. Employers should avoid blanket drug policies that fail to account for medical realities and employee rights. As litigation proceeds, this case may set important precedents for how companies implement drug testing policies in compliance with federal disability law.